financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Keeps Sell Opinion On Adss Of Petroleo Brasileiro S.a.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Keeps Sell Opinion On Adss Of Petroleo Brasileiro S.a.
May 15, 2024 7:57 AM

10:30 AM EDT, 05/15/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

Our 12-month target price of $14, up $1, reflects a 5.2x multiple of enterprise value to projected 2025 EBITDA, slightly below U.S. integrated oil peers, on concerns that weak capital allocation policies are on the horizon. We cut our 2024 earnings per ADS estimate by BRL1.36 to BRL17.48 and lift 2025's by BRL0.94 to BRL16.04. Q1 earnings per ADS of BRL3.65 vs. BRL5.85, missed consensus by BRL0.31. Shares are under pressure today, with Reuters noting that CEO Jean Paul Prates has been asked to step down by Brazil's President Lula. Prates is apparently being replaced by Magda Chambriard, former head of Brazil's energy agency ANP from 2012 to 2016. On the one hand, Chambriard has an engineering background, which we think is a plus. However, we believe the move stems from an effort by Lula to use PBR in a populist fashion, which runs the risk of 1) capital allocation into low-return project boondoggles, 2) lower dividend growth, and 3) renewed subsidies for refined products.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Reiterates Sell Opinion On Shares Of Ferrari N.v.
Research Alert: CFRA Reiterates Sell Opinion On Shares Of Ferrari N.v.
Oct 9, 2025
10:15 AM EDT, 10/09/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our 12-month target at $350, based on a 2026 P/E of 30x, a justified discount to RACE's 10-year average forward P/E multiple of 40x. Our adjusted EPS estimates...
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Pepsico, Inc.
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Pepsico, Inc.
Oct 9, 2025
01:45 PM EDT, 10/09/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our 12-month target of $170, based on a 2026 P/E of 20.2x, a justified discount to PEP's five-year mean forward P/E of 23.0x. We maintain our adjusted EPS...
Research Alert: CFRA Lowers Opinion On Real Estate To Underweight From Marketweight
Research Alert: CFRA Lowers Opinion On Real Estate To Underweight From Marketweight
Oct 8, 2025
02:20 PM EDT, 10/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We are lowering our opinion on the Real Estate sector to underweight given its vulnerability to potential disappointment if Fed rate cuts prove less aggressive than market expectations, combined with...
Research Alert: CFRA Raises Opinion On Health Care To Marketweight From Underweight
Research Alert: CFRA Raises Opinion On Health Care To Marketweight From Underweight
Oct 8, 2025
01:40 PM EDT, 10/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: After Pfizer Inc. (PFE 26 ****) and the U.S. government struck the first Most Favored Nation (MFN) drug pricing deal to lower drug prices in the U.S., we see policy...
Copyright 2023-2025 - www.financetom.com All Rights Reserved